These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34862215)

  • 61. Spanish Guidelines on Treatment of Bronchiectasis in Adults.
    Martínez-García MÁ; Máiz L; Olveira C; Girón RM; de la Rosa D; Blanco M; Cantón R; Vendrell M; Polverino E; de Gracia J; Prados C
    Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):88-98. PubMed ID: 29128129
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Inhaled antibiotics for the management of non cystic fibrosis bronchiectasis].
    Berra G; Chappuis-Gisin É; Soccal PM; Plojoux J
    Rev Med Suisse; 2017 Nov; 13(583):2001-2004. PubMed ID: 29143505
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Non-cystic fibrosis bronchiectasis.
    Murray MP; Hill AT
    Clin Med (Lond); 2009 Apr; 9(2):164-9. PubMed ID: 19435127
    [No Abstract]   [Full Text] [Related]  

  • 64. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
    Venning V; Bartlett J; Jayaram L
    Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?
    Visser SK; Bye PTP; Fox GJ; Burr LD; Chang AB; Holmes-Liew CL; King P; Middleton PG; Maguire GP; Smith D; Thomson RM; Stroil-Salama E; Britton WJ; Morgan LC
    Lung; 2019 Dec; 197(6):803-810. PubMed ID: 31691027
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
    Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
    Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.
    Chalmers JD; Sethi S
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):18. PubMed ID: 28270656
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies.
    Abu Dabrh AM; Hill AT; Dobler CC; Asi N; Farah WH; Haydour Q; Wang Z; Benkhadra K; Prokop LJ; Murad MH
    BMJ Evid Based Med; 2018 Jun; 23(3):96-103. PubMed ID: 29678900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brazilian consensus on non-cystic fibrosis bronchiectasis.
    Pereira MC; Athanazio RA; Dalcin PTR; Figueiredo MRF; Gomes M; Freitas CG; Ludgren F; Paschoal IA; Rached SZ; Maurici R
    J Bras Pneumol; 2019 Aug; 45(4):e20190122. PubMed ID: 31411280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Paediatric and adult bronchiectasis: Monitoring, cross-infection, role of multidisciplinary teams and self-management plans.
    Navaratnam V; Forrester DL; Eg KP; Chang AB
    Respirology; 2019 Feb; 24(2):115-126. PubMed ID: 30500093
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non cystic fibrosis bronchiectasis.
    Dagli E
    Paediatr Respir Rev; 2000 Mar; 1(1):64-70. PubMed ID: 16263448
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.
    Kwok WC; Ho JCM; Tam TCC; Ip MSM; Lam DCL
    Respir Res; 2021 Apr; 22(1):132. PubMed ID: 33910573
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Non-cystic-fibrosis bronchiectasis: a perspective from South America.
    Marostica PJ; Fischer GB
    Paediatr Respir Rev; 2006 Dec; 7(4):275-80. PubMed ID: 17098642
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
    Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery].
    Vendrell M; de Gracia J; Olveira C; Martinez-Garcia MA; Girón R; Máiz L; Cantón R; Coll R; Escribano A; Solé A
    Arch Bronconeumol; 2008 Nov; 44(11):629-40. PubMed ID: 19007570
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Macrolide antibiotics for bronchiectasis.
    Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lobar distribution in non-cystic fibrosis bronchiectasis predicts bacteriologic pathogen treatment.
    Izhakian S; Wasser WG; Fuks L; Vainshelboim B; Fox BD; Fruchter O; Kramer MR
    Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):791-6. PubMed ID: 26873379
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.
    Chang AB; Bilton D
    Thorax; 2008 Mar; 63(3):269-76. PubMed ID: 18308962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.